Zealand Pharma Loses Fifth of Value After Trial Dropouts
Danish biotech Zealand Pharma saw its stock slide after disclosing a 20% dropout rate in its weight-loss drug trial d...
Examine funds that maximize after-tax gains for retirement. This overview focuses on tax efficiency and long-term retirement growth.
27,364 articlesDanish biotech Zealand Pharma saw its stock slide after disclosing a 20% dropout rate in its weight-loss drug trial d...
Analysts say Bitcoin’s price cycles show a repeatable cadence. With a high in October 2025 and a window around Octobe...
Circle’s 2025 results highlight a costly reality: rapid USDC growth came with big distribution costs, uneven margins,...
Oil prices plummet after a Reuters-style rumor that the G7 may tap 400 million barrels from strategic reserves. Crypt...
What happened in Designer Brands (DBI) 2025 earnings, and what it means for investors in 2026. This guide breaks down...
A leading AI software name slammed in a broad market rotation now sits well off its highs. This guide breaks down whe...
Bitcoin climbs after Trump suggests an Iran deal is near, sparking a risk-on move in crypto markets. Prices hit aroun...
Take-Two CEO Strauss Zelnick is directing a record-setting $1.5 billion launch budget for GTA VI, a move investors wi...
Lucid Group sparked a sharp rally after the CEO denied bankruptcy rumors and take-private chatter. This article break...
Hims Hers Health shares jumped after news of a Novo Nordisk collaboration. This guide breaks down what the deal could...
Anchorage Digital Bank announced a regulatory milestone, bringing Tron inside the U.S. regulatory perimeter. The move...
A prompt-driven AI model inspired by Altman and CHATGPT outlines a potential XRP breakout by the end of June 2026. Th...